Overview
- Explores the current status and future prospects of stem cell banking
- Examines all aspects of stem cell banking from type of bank and type of stem cells, regulatory landscape, public versus private, and other funding components
- Highlights stem cell banking industry in new markets such as Brazil, Russia, India, and China
- Includes supplementary material: sn.pub/extras
Part of the book series: Stem Cell Biology and Regenerative Medicine (STEMCELL)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (14 chapters)
-
General Issues in Stem Cell Banking
-
Stem Cell Banking Worldwide
Keywords
About this book
This book exemplifies experience across the globe in banking of cord blood, mesenchymal, embryonic and induced pluripotent stem cells for clinical use from the United States, Canada, the European Union, Switzerland and Japan to Iran, India and Serbia. The concerns are similar regardless of stem cell type or origin. Implementing core values and common standards depend often on specific circumstances of political and economic setting, which makes flexibility as important as systematic planning. Banking of stem cells is not just building a repository and storing samples. The planning, design, construction and maintenance involve multiple skilled professionals. Stem cell banks are points where technology and medicine converge with ethics, laws and regulations. If properly designed and organized, their utilization will have a broad impact not only on the scientific community and medical professionals but also on the general public.
Editors and Affiliations
About the editor
Dr. Dusko Ilic obtained his MD degree and BSci in Molecular Biology at the University of Belgrade, his PhD at the Tokyo University, Japan and he completed postdoctoral training at the University of California in San Francisco. Before joining King’s College School of Medicine in London, he held positions of Adjunct Associate Professor at the University of California San Francisco, Consultant at the Veteran Affairs Medical Center, San Francisco and as Director of R&D at StemLifeLine, a California-licensed stem cell company. Dr. Ilic's current research interests are human embryonic stem (hES) cells, induced pluripotent stem (iPS) cells, and mesenchymal stem cells and their potential in drug discovery and cell-based therapies.
Bibliographic Information
Book Title: Stem Cell Banking
Editors: Dusko Ilic
Series Title: Stem Cell Biology and Regenerative Medicine
DOI: https://doi.org/10.1007/978-1-4939-0585-0
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media New York 2014
Hardcover ISBN: 978-1-4939-0584-3Published: 06 May 2014
Softcover ISBN: 978-1-4939-5560-2Published: 23 August 2016
eBook ISBN: 978-1-4939-0585-0Published: 05 May 2014
Series ISSN: 2196-8985
Series E-ISSN: 2196-8993
Edition Number: 1
Number of Pages: XVII, 168
Number of Illustrations: 5 b/w illustrations, 21 illustrations in colour
Topics: Stem Cells, Regenerative Medicine/Tissue Engineering, Cell Biology
Industry Sectors: Biotechnology